Passage BIO Inc
For the period ended May 24, 2024. Filed Apr 9, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 24, 2024 · Filed Apr 9, 2024
Contents
Cover page
Show cover page
DEF 14A 1 tm249796d1_def14a.htm DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
****WASHINGTON, D.C. 20549
SCHEDULE 14A
****(Rule 14a-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrantx Filed by a Party other than the Registrant¨
Check the appropriate box:
| ¨ | Preliminary Proxy Statement |
|---|
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|---|
| x | Definitive Proxy Statement |
|---|
| ¨ | Definitive Additional Materials |
|---|
| ¨ | Soliciting Material Pursuant to §240.14a-12 |
|---|
PASSAGE BIO, INC.
****(Name of Registrant as Specified In Its Charter)
N/A
****(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| Payment of Filing Fee (Check the appropriate box): | |
|---|---|
| x | No fee required. |
| ¨ | Fee paid previously with preliminary materials. |
| ¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
**PASSAGE BIO, INC.
2005 Market Street, 39 th Floor
**NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To Be Held May 21, 2024
To Our Stockholders:
NOTICE IS HEREBY GIVEN that the 2024 Annual Meeting of Stockholders of Passage Bio, Inc. will be held via a virtual meeting. You will be able to participate in the 2024 Annual Meeting and vote during the 2024 Annual Meeting via live webcast by visiting www.virtualshareholdermeeting.com/PASG2024 on Tuesday, May 21, 2024, at 9:00 a.m. Eastern Time. We believe that a virtual stockholder meeting provides greater access to those who may want to attend and therefore we have chosen this over an in-person meeting. It is important that you retain a copy of the control number found on the proxy card or voting instruction form, as such number will be required in order for stockholders to gain access to the virtual meeting.
We are holding the meeting for the following purposes, which are more fully described in the accompanying proxy statement:
| 1. | To elect two Class I directors, to serve a three-year term through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal. |
| 2. | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. |
In addition, stockholders may be asked to consider and vote upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
Only stockholders of record at the close of business on March 28, 2024, are entitled to receive notice of, and to vote at, the meeting and any adjournments thereof. On or about April 9, 2024, we expect to mail to stockholders a Notice of Internet Availability of Proxy Materials (the Notice of Internet Availability) containing instructions on how to access our proxy statement for our 2024 Annual Meeting and our 2023 Annual Report on Form 10-K to stockholders. The Notice of Internet Availability also provides instructions on how to vote through the internet or by telephone and includes instructions on how to receive paper copies of the proxy materials by mail, if desired.
For ten days prior to the meeting, a complete list of the stockholders entitled to vote at the meeting will be available upon request by any stockholder for any purpose relating to the meeting. Stockholders can request the list of stockholders by contacting our investor relations team at investors@passagebio.com.
Your vote as a Passage Bio, Inc. stockholder is very important. Each share of common stock that you own represents one vote.
For questions regarding your stock ownership, you may contact our Corporate Secretary at investors@passagebio.com or, if you are a registered holder, our transfer agent, Computershare Trust Company, N.A. by email through their website at www.computershare.com/contactus or by phone at (800) 736-3001. Whether or not you expect to attend the meeting, we encourage you to read the proxy statement and vote through the internet or by telephone, or to request, sign and return your proxy card as soon as possible, so that your shares may be represented at the meeting. For specific instructions on how to vote your shares, please refer to the section entitled “General Proxy Information” in the proxy statement.
By Order of the Board of Directors,
William Chou, M.D,
President and Chief Executive Officer
Philadelphia, Pennsylvania
April 9, 2024
Important Notice Regarding the Availability of Proxy Materials for the virtual Annual Meeting of Stockholders to be held on May 21, 2024: the Proxy Statement and our 2023 Annual Report on Form 10-K are available at www.ProxyVote.com. You will need the control number included on your proxy card or voting instruction form, or included in the e-mail to you if you received the proxy materials by e-mail, as such number will be required in order for stockholders to gain access to the virtual meeting.
PASSAGE BIO, INC.
PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS
TABLE OF CONTENTS
| Page | |
|---|---|
| INFORMATION ABOUT SOLICITATION AND VOTING | 1 |
| GENERAL INFORMATION ABOUT THE MEETING | 1 |
| GENERAL PROXY INFORMATION | 2 |
| CORPORATE GOVERNANCE STANDARDS AND DIRECTOR INDEPENDENCE | 5 |
| PROPOSAL NO. 1 ELECTION OF CLASS I DIRECTORS | 10 |
| PROPOSAL NO. 2 RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 17 |
| REPORT OF THE AUDIT COMMITTEE | 18 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 19 |
| DELINQUENT SECTION 16(A) REPORTS | 21 |
| EXECUTIVE OFFICERS | 22 |
| EXECUTIVE COMPENSATION | 23 |
| EQUITY COMPENSATION PLAN INFORMATION | 32 |
| CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS | 33 |
| ADDITIONAL INFORMATION | 34 |
| OTHER MATTERS | 35 |
**PASSAGE BIO, INC.
2005 Market Street, 39th Floor
PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS
April 9, 2024
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.